the aid library

LIST OPTIONS

Filter

4888

Sort by:

Direction:

Download (548)

View PDF (2107)

Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics
recommended

World Health Organization WHO (2017) C_WHO

The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac... more

Download (289)

View PDF (421)

The FORTA List “ Fit for The Aged“

Pazan, F.; C. Weiß and M. Wehling Universität Heidelberg (2018) C2

Expert Consensus Validation 2018. This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap... more

Download (212)

View PDF (341)

Update on Ebola drug trial: two strong performers identified

World Health Organization WHO (2019) C_WHO

Download (374)

View PDF (420)

A8 e-Therapy using computer and mobile technologies in treatment

Karolina Stasiak & Sally Merry IACAPAP (2015) C2

This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o... more

Download (126)

View PDF (196)

B1 Perinatal and early childhood risk and protective factor and disorders: early maltreatment and exposure to violence

Susan MK Tan, Norazlin Kamal Nor, Loh Sit Fong, Suzaily Wahab, Sheila Marimuthu & Chan Lai Fong IACAPAP (2015) C1

Download (197)

View PDF (253)

C1 Intellectual disability

Xiaoyan Ke & Jing Liu IACAPAP (2015) C1

Download (275)

View PDF (302)

Attention deficit hyperactivity disorder (Russian version edited by O Dolenko, D Martsenkovskyi) Расстройство дефицита внимания и гиперактивности

Moriyama TS, Cho AJM, Verin RE et al. International Association for Child and Adolescent Psychiatry and Allied Professions (2012) C1

This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and pract... more

Download (159)

View PDF (248)

J11. The practice of child mental health nurses

Kathleen R Delaney, Janice L. Cooper & Sylvia Nshemerewire IACAPAP (2015) C1

Download (608)

View PDF (1021)

Research Monograph of the Updated 2010-2016 Philippine Plan of Action to Control Tuberculosis

National TB Control Program, Department of Health (2014) C1

Download (56)

View PDF (600)

What Kind of Statetegic Policy for a Better Taking Care of Tuberculosis in Senegal

Abdoulaye F., M. Bop, A. Kane Journal of Tropical Diseases (2013) CC

HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t... more

Download (106)

View PDF (165)

Dengue epidemiology

Jing, Q.; Wang, M. Global Health Journal (2019) CC

Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr... more

Download (103)

View PDF (635)

Reimagining the fight against Chagas disease

Novartis (2020) C1

Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro... more

Download (61)

View PDF (319)

Webinar on Cutaneous Leishmaniasis

Yamada, H.; Kita, K. Nagasaki University School of Tropical Medicine and Global Health (2016) CC

Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often... more

Download (62)

View PDF (311)

Webinar on Cutaneous Leishmaniasis and the summary of the proceedings are now available

Yamada, H.; Kita, K. Nagasaki University School of Tropical Medicine and Global Health (2016) CC

Download (77)

View PDF (319)

Video recording of Webinar on Cutaneous Leishmaniasis

Yamada, H.; Kita, K. Nagasaki University School of Tropical Medicine and Global Health (2016) CC

Download (78)

View PDF (309)

Leishmaniasis Webinar

Yamada, H.; Kita, K. Nagasaki University School of Tropical Medicine and Global Health (2016) CC

Download (77)

View PDF (417)

Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis

Krentel, A.; Gyapong, M.; McFarland, D.A.; Ogundahunsi, O.; Titaley, C.R.; Addiss, D.G. Oxford Academic - International Health (2021) CC

Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c... more

Download (72)

View PDF (235)

Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review

Wright J.E., Werkman M., Dunn J.C. et al Parasites and Vectors (2018) C2

Background: The human helminth infections include ascariasis, trichuriasis, hookworm infections, schistosomiasis, lymphatic filariasis (LF) and onchocerciasis. It is estimated that almost 2 billion people worldwide are infected with helminths. Whilst the WHO treatment guidelines for helminth infecti...ons are mostly aimed at controlling morbidity, there has been a recent shift with some countries moving towards goals of disease elimination through mass drug administration, especially for LF and onchocerciasis. However, as prevalence is driven lower, treating entire populations may no longer be the most efficient or cost-effective strategy. Instead, it may be beneficial to identify individuals or demographic groups who are persistently infected, often termed as being “predisposed” to infection, and target treatment at them. Methods: The authors searched Embase, MEDLINE, Global Health, and Web of Science for all English language, humanbased papers investigating predisposition to helminth infections published up to October 31st, 2017. The varying definitions used to describe predisposition, and the statistical tests used to determine its presence, are summarised. Evidence for predisposition is presented, stratified by helminth species, and risk factors for predisposition to infection are identified and discussed. Results: In total, 43 papers were identified, summarising results from 34 different studies in 23 countries. Consistent evidence of predisposition to infection with certain species of human helminth was identified. Children were regularly found to experience greater predisposition to Ascaris lumbricoides, Schistosoma mansoni and S. haematobium than adults. Females were found to be more predisposed to A. lumbricoides infection than were males. Household clustering of infection was identified for A. lumbricoides, T. trichiura and S. japonicum. Ascaris lumbricoides and T. trichiura also showed evidence of familial predisposition. Whilst strong evidence for predisposition to hookworm infection was identified, findings with regards to which groups were affected were considerably more varied than for other helminth species. Conclusion: This review has found consistent evidence of predisposition to heavy (and light) infection for certain human helminth species. However, further research is needed to identify reasons for the reported differences between demographic groups. Molecular epidemiological methods associated with whole genome sequencing to determine ‘who infects whom’ may shed more light on the factors generating predisposition. more

Download (93)

View PDF (136)

Scoping the needs and gaps of endemic countries in the onchocerciasis elimination programme: findings report, June 2023

World Health Organization WHO (2024) C_WHO

Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030 (“the road map”) sets explicit targets for the elimination of onchocerciasis by 2030, including eliminating the need for mass drug administration (MDA) of ivermectin in at least... more

Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics recommended

Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics
recommended